Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
0.00
-0.2900 (-6.76%)
At close: Mar 31, 2025, 4:00 PM
3.955
+3.955 (0.00%)
After-hours: Mar 31, 2025, 4:37 PM EDT

Camp4 Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Net Income
-51.79-49.29-44.19
Depreciation & Amortization
1.71.680.88
Stock-Based Compensation
4.032.911.38
Other Operating Activities
1.831.821.69
Change in Accounts Payable
0.17-1.121.33
Change in Unearned Revenue
0.39--
Change in Other Net Operating Assets
-1.88-0.150.37
Operating Cash Flow
-45.56-44.16-38.54
Capital Expenditures
-0.44-0.68-4.03
Investing Cash Flow
-0.44-0.68-4.03
Long-Term Debt Issued
-0.71-
Long-Term Debt Repaid
-0.82-0.59-0.09
Net Debt Issued (Repaid)
-0.820.12-0.09
Issuance of Common Stock
76.470.190.06
Other Financing Activities
-3.98--
Financing Cash Flow
71.660.3100.16
Net Cash Flow
25.66-44.5357.59
Free Cash Flow
-46-44.83-42.57
Free Cash Flow Margin
-7055.67%-12809.43%-
Free Cash Flow Per Share
-9.81-113.51-136.31
Levered Free Cash Flow
-26.54-30.18-
Unlevered Free Cash Flow
-26.52-30.16-
Change in Net Working Capital
-1.371.65-
Updated Nov 21, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q